W. Rowlands

Director/Board Member presso A-LABS CAPITAL II CORP.

62 anni

Health Technology

Non-Energy Minerals

Finance

Profilo

W.
Bruce Rowlands is an Independent Director at A-Labs Capital II Corp.
He was the Chairman of XORTX Therapeutics, Inc. from 2018 to 2021.
He was a Director at Talisker Resources Ltd.
in 2018.
He also served as a Director at XORTX Pharma Corp.
He was a Director & Vice President at Dominick & Dominick Securities, Inc. from 1999 to 2003.
He was the Senior Vice President-Planning & Public Affairs at Aptose Biosciences, Inc. from 2003 to 2005.
Currently, he holds the position of Independent Director at A-Labs Capital II Corp.

Posizioni attive di W. Rowlands

Società	Posizione	Inizio
A-LABS CAPITAL II CORP.	Director/Board Member	05/09/2018

Tutte le posizioni attive di W. Rowlands

Precedenti posizioni note di W. Rowlands

Società	Posizione	Fine
XORTX THERAPEUTICS INC.	Chairman	20/12/2021
TALISKER RESOURCES LTD.	Chief Executive Officer	15/03/2018
APTOSE BIOSCIENCES INC.	Public Communications Contact	01/01/2005
Dominick & Dominick Securities, Inc.	Director/Board Member	01/01/2003
XORTX Pharma Corp. XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada.	Director/Board Member	-

Vedi nel dettaglio l'esperienza di W. Rowlands

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di W. Rowlands

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	4
APTOSE BIOSCIENCES INC.	Health Technology
TALISKER RESOURCES LTD.	Non-Energy Minerals
XORTX THERAPEUTICS INC.	Health Technology
A-LABS CAPITAL II CORP.	Finance

Aziende private	2
XORTX Pharma Corp. XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada.	Health Technology
Dominick & Dominick Securities, Inc.